Literature DB >> 31829469

NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production.

Junhua Wu1,2, Danyang Wu1, Longyao Zhang1, Chuxuan Lin1, Jiahao Liao1, Ruyin Xie1, Zhulin Li1, Siyang Wu1, Aimin Liu1, Weining Hu1, Yang Xi1, Shizhong Bu1, Fuyan Wang1.   

Abstract

High-fat diet (HFD) induced hepatic endoplasmic reticulum (ER) stress drives insulin resistance (IR) and steatosis. NK cells in adipose tissue play an important role in the pathogenesis of IR in obesity. Whether NK cells in the liver can induce hepatic ER stress and thus promote IR in obesity is still unknown. We demonstrate that HFD-fed mice display elevated production of proinflammatory cytokine osteopontin (OPN) in hepatic NK cells, especially in CD49a+ DX5- tissue-resident NK (trNK) cells. Obesity-induced ER stress, IR, and steatosis in the liver are ameliorated by ablating NK cells with neutralizing antibody in HFD-fed mice. OPN treatment enhances the expression of ER stress markers, including p-PERK, p-eIF2, ATF4, and CHOP in both murine liver tissues and HL-7702, a human liver cell line. Pretreatment of HL-7702 cells with OPN promotes hyperactivation of JNK and subsequent decrease of tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), resulting in impaired insulin signaling, which can be reversed by inhibiting ER stress. Collectively, we demonstrate that hepatic NK cells induce obesity-induced hepatic ER stress, and IR through OPN production. ©2019 Society for Leukocyte Biology.

Entities:  

Keywords:  ER stress, IR, NK cells, obesity, OPN, steatosis; inflammation; tissue resident

Year:  2019        PMID: 31829469     DOI: 10.1002/JLB.3MA1119-173R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

Review 1.  ER stress in obesity pathogenesis and management.

Authors:  Amir Ajoolabady; Simin Liu; Daniel J Klionsky; Gregory Y H Lip; Jaakko Tuomilehto; Sina Kavalakatt; David M Pereira; Afshin Samali; Jun Ren
Journal:  Trends Pharmacol Sci       Date:  2021-12-08       Impact factor: 14.819

2.  Tissue-Specific Gamma-Flicker Light Noninvasively Ameliorates Retinal Aging.

Authors:  Wang Sheng; Da Lv; Ze-Kai Cui; Yi-Ni Wang; Bin Lin; Shi-Bo Tang; Jian-Su Chen
Journal:  Cell Mol Neurobiol       Date:  2021-10-26       Impact factor: 4.231

Review 3.  Role of Innate lymphoid Cells in Obesity and Insulin Resistance.

Authors:  Hong Chen; Lijun Sun; Lu Feng; Yue Yin; Weizhen Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-27       Impact factor: 6.055

Review 4.  Regulation of cellular immunity by activating transcription factor 4.

Authors:  Debasmita Mukherjee; Lena S Bercz; Molly A Torok; Thomas A Mace
Journal:  Immunol Lett       Date:  2020-09-28       Impact factor: 3.685

5.  Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance.

Authors:  Lu Qiao; Lili Men; Shanshan Yu; Junjie Yao; Yu Li; Mingming Wang; Ying Yu; Ning Wang; Liyuan Ran; Yingjie Wu; Jianling Du
Journal:  Cell Death Dis       Date:  2022-03-28       Impact factor: 9.685

6.  Integrative multiomic analyses of dorsal root ganglia in diabetic neuropathic pain using proteomics, phospho-proteomics, and metabolomics.

Authors:  Megan Doty; Sijung Yun; Yan Wang; Minghan Hu; Margaret Cassidy; Bradford Hall; Ashok B Kulkarni
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996

7.  The Effect of a Comprehensive Life-Style Intervention Program of Diet and Exercise on Four Bone-Derived Proteins, FGF-23, Osteopontin, NGAL and Sclerostin, in Overweight or Obese Children and Adolescents.

Authors:  Sofia I Karampatsou; George Paltoglou; Sofia M Genitsaridi; Penio Kassari; Evangelia Charmandari
Journal:  Nutrients       Date:  2022-09-13       Impact factor: 6.706

Review 8.  Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease.

Authors:  María Luz Martínez-Chantar; Teresa C Delgado; Naiara Beraza
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.